Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine

Uncertainty surrounding the risk of developing and dying from Thrombosis and Thrombocytopenia Syndrome (TTS) associated with the AstraZeneca (AZ) COVID-19 vaccine may contribute to vaccine hesitancy. A model is urgently needed to combine and effectively communicate evidence on the risks versus benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayfield, Helen J., Lau, Colleen L., Sinclair, Jane E., Brown, Samuel J., Baird, Andrew, Litt, John, Vuorinen, Aapeli, Short, Kirsty R., Waller, Michael, Mengersen, Kerrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989774/
https://www.ncbi.nlm.nih.gov/pubmed/35450781
http://dx.doi.org/10.1016/j.vaccine.2022.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989774/
https://www.ncbi.nlm.nih.gov/pubmed/35450781
http://dx.doi.org/10.1016/j.vaccine.2022.04.004

Ejemplares similares